BAN OPIOIDS

WELCOME TO BANOPIOIDS.COM

BanOpioids.com is a policy-forward phrase: ban + opioids for advocacy campaigns, hospital opioid-stewardship education, and community awareness brands that want an unmistakable call-to-action URL. Use it for a nonprofit campaign microsite, a health-system stewardship portal, or a public-education hub—aftermarket inventory, not a product endorsement of any legislation. No ASHP spend cite forced here; the name sells advocacy clarity, distinct from AbuseRx (treatment pharmacy) and FentanylRx (class specialty string).

Natural buyers include specialty Rx brands, PBM / formulary desks, and mail-order pharmacies. Concrete use-case: Ship a banopioids-led refill hub, formulary explainer, or specialty therapy microsite where the Rx/clinical cue is already in the hostname patients and partners type.

ASHP reported U.S. prescription drug spending at $915.2B in 2025 (+12.7% YoY), on a path toward $1T—context for pharmacy, formulary, and Rx-brand doors like banopioids.com. Cite spend only as category demand for THIS hostname, never as a fabricated local TAM.

Why Choose BANOPIOIDS.COM

• Advocacy phrase exact: Ban + Opioids is a clear campaign headline in the URL.
• Stewardship / education fit: Nonprofit campaigns, hospital stewardship, community awareness.
• Not a retail opioid storefront: Policy and education positioning—not dispensing marketing.
• Sibling-clear: BanOpioids ≠ AbuseRx treatment ≠ FentanylRx class pharmacy.
• banopioids exact-match clarity: The hostname says banopioids without a tagline—buyers and partners grasp the lane on sight.
• Buyer-ready use-cases on banopioids.com: Works for launch pages, redirects, and paid-media destinations that need THIS string in the URL.

WHAT DOES ALAN ISAACS THINK?

"banopioids.com is the banopioids door—buy it when the brand story starts with THIS string, not a generic niche template."

Alan Isaacs, Finance Manager

Contact Alan Isaacs via Email